Trials / Not Yet Recruiting
Not Yet RecruitingNCT05595187
Concomitant Tricuspid Repair in Patients With Left Heart Surgery
Concomitant Tricuspid Repair in Patients With Left Heart Surgery: Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Tricuspid regurgitation is common in patients with severe left heart diseases, such as degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform concomitant tricuspid-valve repair during left heart surgery in patients who have mild tricuspid regurgitation. To inform decision making, we will conduct a multicenter, randomized trial to assess the benefits and risks of tricuspid-valve repair at the time of left heart diseases in patients with mild tricuspid regurgitation who were undergoing surgery for left heart surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tricuspid repair | Tricuspid repair included suture placement and the type of prosthetic annuloplasty. |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2022-10-26
- Last updated
- 2023-12-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05595187. Inclusion in this directory is not an endorsement.